ORO Labs, a San Francisco and London–based procurement orchestration platform for global enterprises, has secured $100 million in Series C funding.
Investors
The round was led by Brighton Park Capital and Goldman Sachs Alternatives, with participation from existing investors Norwest Venture Partners, B Capital, XYZ Capital, and Felicis.
Brighton Park Capital is a New York–based investment firm focused on entrepreneur-led, growth-stage software, healthcare, and tech-enabled services companies. The firm invests in companies that provide highly innovative solutions in partnership with strong management teams. Brighton Park also brings purpose-built, value-add capabilities tailored to the unique needs of its portfolio companies.
Goldman Sachs Alternatives is a global investor in alternative assets, managing more than $625 billion across private equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Since 2003, the Growth Equity team at Goldman Sachs Alternatives has invested more than $13 billion in growth-stage, technology-driven businesses across multiple industries, including enterprise technology, financial technology, consumer, and healthcare.
Mike Gregoire of Brighton Park Capital and Clare Greenan, from the Growth Equity team at Goldman Sachs Alternatives, will join ORO Labs’ Board of Directors.
ORO Labs Use of Funds
The company will use the funding to accelerate global expansion, enhance its AI-driven procurement orchestration platform, and scale customer success and deployment capabilities.
About ORO Labs
Led by CEO Sudhir Bhojwani, ORO Labs is a software company developing a procurement orchestration platform that helps large enterprises automate and streamline procurement operations. Its AI-powered no-code platform delivers intuitive user experiences, enabling businesses to reduce cycle times, decrease risk through end-to-end process visibility, and increase agility in response to change. ORO Labs serves global enterprises, including The Coca-Cola Company, Siemens Energy, and Novartis. Its platform is deployed in over 100 countries across industries such as life sciences, financial services, manufacturing, and telecommunications.
Funding Details
Company: ORO Labs, Inc.
Raised: $100.0M
Round: Series C
Funding Date: March 2026
Lead Investor: Brighton Park Capital, Goldman Sachs Alternatives
Additional Investors: Norwest Venture Partners, B Capital, XYZ Capital, Felicis
Company Website: https://www.orolabs.ai/
Software Category: Procurement Orchestration Platform
Source: https://www.bpc.com/insights/oro-labs-raises-100m-to-serve-as-the-catalyst-for-agentic-procurement